{
	"edges": [
		{
			"source_id": "1.1",
			"target_id": "1.2",
			"type": "1"
		},
		{
			"source_id": "1.2",
			"target_id": "1.3",
			"type": "0"
		},
		{
			"source_id": "1.3",
			"target_id": "1.4",
			"type": "2"
		},
		{
			"source_id": "1.4",
			"target_id": "1.5",
			"type": "0"
		},
		{
			"source_id": "1.5",
			"target_id": "1.6",
			"type": "0"
		},
		{
			"source_id": "1.5",
			"target_id": "1.11",
			"type": "0"
		},
		{
			"source_id": "1.5",
			"target_id": "1.12",
			"type": "0"
		},
		{
			"source_id": "1.5",
			"target_id": "1.13",
			"type": "0"
		},
		{
			"source_id": "1.6",
			"target_id": "1.7",
			"type": "0"
		},
		{
			"source_id": "1.7",
			"target_id": "1.8",
			"type": "0"
		},
		{
			"source_id": "1.8",
			"target_id": "1.9",
			"type": "0"
		},
		{
			"source_id": "1.8",
			"target_id": "1.11",
			"type": "2"
		},
		{
			"source_id": "1.9",
			"target_id": "1.10",
			"type": "1"
		},
		{
			"source_id": "1.9",
			"target_id": "1.13",
			"type": "2"
		},
		{
			"source_id": "1.11",
			"target_id": "1.10",
			"type": "1"
		},
		{
			"source_id": "1.12",
			"target_id": "1.10",
			"type": "1"
		},
		{
			"source_id": "1.13",
			"target_id": "1.14",
			"type": "1"
		}
	],
	"nodes": [
		{
			"id": "1.1",
			"text": "HbA1c > 48 mmol/mol?",
			"node_type": "decision",
			"entities": {
				"single": {
					"type": "algorithm_observation_decision_1",
					"id": 1
				}
			}
		},
		{
			"id": "1.2",
			"node_type": "action",
			"text": "UPDATE HbA1c TARGET (48 mmol/mol (7.0%)) 1.6.19",
			"entities": {
				"single": {
					"type": "algorithm_set_goal_1",
					"id": 1
				}
			}
		},
		{
			"id": "1.3",
			"node_type": "decision",
			"text": "STANDARD RELEASE METFORMIN CONTRAINDICATED?",
			"entities": {
				"single": {
					"type": "medication_contraindication_decision_1",
					"id": 1
				}
			}
		},
		{
			"id": "1.4",
			"node_type": "action",
			"text": "OFFER STANDARD RELEASE METFORMIN",
			"entities": {
				"single": {
					"type": "algorithm_offer_medication_1",
					"id": 1
				}
			}
		},
		{
			"id": "1.5",
			"node_type": "action",
			"text": "SET ALERT ON eGFR < 30 STOP METFORMIN",
			"entities": {
				"single": {
					"type": "algorithm_set_alert_1",
					"id": 1
				}
			}
		},
		{
			"id": "1.6",
			"text": "GASTRO INTESTINAL SIDE EFFECTS?",
			"node_type": "decision",
			"entities": {
				"or": [
					{
						"type": "algorithm_condition_decision_1",
						"id": 1
					},
					{
						"type": "algorithm_condition_decision_1",
						"id": 2
					}
				]
			}
		},
		{
			"id": "1.7",
			"text": "STOP STANDARD RELEASE METFORMIN",
			"node_type": "action",
			"entities": {
				"single": {
					"type": "stop_medication_1",
					"id": 1
				}
			}
		},
		{
			"id": "1.8",
			"text": "CONSIDER MODIFIED RELEASE METFORMIN",
			"node_type": "action",
			"entities": {
				"single": {
					"type": "algorithm_consider_medication_1",
					"id": 1
				}
			}
		},
		{
			"id": "1.9",
			"text": "MODIFIED RELEASE METFORMIN NOT TOLERATED?",
			"node_type": "decision",
			"entities": {
				"single": {
					"type": "algorithm_medication_not_tolerated_decision_1",
					"id": 1
				}
			}
		},
		{
			"id": "1.10",
			"text": "STOP MODIFIED RELEASE METFORMIN",
			"node_type": "action",
			"entities": {
				"single": {
					"type": "stop_medication_1",
					"id": 1
				}
			}
		},
		{
			"id": "1.11",
			"text": "eGFR < 30ml/minute/1.73m2",
			"node_type": "decision",
			"entities": {
				"single": {
					"type": "algorithm_observation_decision_1",
					"id": 2
				}
			}
		},
		{
			"id": "1.12",
			"text": "STANDARD RELEASE METFORMIN NOT TOLERATED?",
			"node_type": "decision",
			"entities": {
				"single": {
					"type": "algorithm_medication_not_tolerated_decision_1",
					"id": 1
				}
			}
		},
		{
			"id": "1.13",
			"text": "HbA1c > 58 mmol/mol?",
			"node_type": "decision",
			"entities": {
				"single": {
					"type": "algorithm_observation_decision_1",
					"id": 3
				}
			}
		},
		{
			"id": "1.14",
			"node_type": "action",
			"text": "UPDATE HbA1c TARGET (53 mmol/mol (7.0%))",
			"entities": {
				"single": {
					"type": "algorithm_set_goal_1",
					"id": 2
				}
			}
		},
		{
			"id": "1.15",
			"node_type": "decision",
			"text": "PIOGLITAZONE CONTRAINDICATED?",
			"entities": {
				"single": {
					"type": "medication_contraindication_decision_1",
					"id": 2
				}
			}
		},
		{
			"id": "1.16",
			"text": "CONSIDER PIOGLITAZONE",
			"node_type": "action",
			"entities": {
				"single": {
					"type": "algorithm_consider_medication_1",
					"id": 2
				}
			}
		},
		{
			"id": "1.17",
			"text": "SET ALERT ON PIOGLITAZONE CONTRAINDICATIONS STOP PIOGLITAZONE",
			"node_type": "action",
			"entities": {
				"single": {
					"type": "algorithm_set_alert_2",
					"id": 1
				}
			}
		},
		{
			"id": "1.18",
			"text": "HbA1c > 58 mmol/mol?",
			"node_type": "decision",
			"entities": {
				"single": {
					"type": "algorithm_observation_decision_1",
					"id": 3
				}
			}
		},
		{
			"id": "1.19",
			"node_type": "action",
			"text": "UPDATE HbA1c TARGET (58 mmol/mol (7.5%))",
			"entities": {
				"single": {
					"type": "algorithm_set_goal_1",
					"id": 3
				}
			}
		},
		{
			"id": "1.20",
			"node_type": "decision",
			"text": "SU / PIOGLITAZONE NOT APPROPRIATE?",
			"entities": {
				"or": [
					{
						"type": "algorithm_medication_contraindication_decision_1",
						"id": 2
					},
					{
						"type": "algorithm_medication_contraindication_decision_1",
						"id": 3
					}
				]
			}
		},
		{
			"id": "1.21",
			"node_type": "decision",
			"text": "SGLT-2i CONTRAINDICATED?",
			"entities": {
				"single": {
					"type": "algorithm_medication_contraindication_decision_1",
					"id": 4
				}
			}
		},
		{
			"id": "1.22",
			"node_type": "action",
			"text": "LET M1 ∈ {DAPAGLIFLOZIN, CANAGLIFLOZIN, EMPAGLIFLOZIN, ERTUGLIFLOZIN}",
			"entities": {
				"single": {
					"type": "algorithm_medication_choice_1",
					"id": 1,
					"code": "M1"
				}
			}
		},
		{
			"id": "1.23",
			"node_type": "decision",
			"text": "M1 CONTRAINDICATED?",
			"entities": {
				"single": {
					"type": "algorithm_medication_contraindication_decision_1",
					"code": "M1"
				}
			}
		},
		{
			"id": "1.24",
			"text": "CONSIDER M1",
			"node_type": "action",
			"entities": {
				"single": {
					"type": "algorithm_consider_medication_1",
					"code": "M1"
				}
			}
		},
		{
			"id": "1.25",
			"text": "HbA1c > 58 mmol/mol?",
			"node_type": "decision",
			"entities": {
				"single": {
					"type": "algorithm_observation_decision_1",
					"id": 3
				}
			}
		},
		{
			"id": "1.26",
			"node_type": "decision",
			"text": "DPP-4i CONTRAINDICATED?",
			"entities": {
				"single": {
					"type": "algorithm_medication_contraindication_decision_1",
					"id": 5
				}
			}
		},
		{
			"id": "1.27",
			"node_type": "action",
			"text": "LET M2 ∈ {ALOGLIPTIN, LINGLIPTIN, SAXAGLIPTIN, SITAGLIPTIN, VILDAGLIPTIN}",
			"entities": {
				"single": {
					"type": "algorithm_medication_choice_1",
					"id": 2,
					"code": "M2"
				}
			}
		},
		{
			"id": "1.28",
			"node_type": "decision",
			"text": "M2 CONTRAINDICATED?",
			"entities": {
				"single": {
					"type": "algorithm_medication_contraindication_decision_1",
					"code": "M2"
				}
			}
		},
		{
			"id": "1.29",
			"text": "CONSIDER M2",
			"node_type": "action",
			"entities": {
				"single": {
					"type": "algorithm_consider_medication_1",
					"code": "M2"
				}
			}
		},
		{
			"id": "1.30",
			"text": "HbA1c > 58 mmol/mol?",
			"node_type": "decision",
			"entities": {
				"single": {
					"type": "algorithm_observation_decision_1",
					"id": 3
				}
			}
		},
		{
			"id": "1.31",
			"node_type": "action",
			"text": "UPDATE HbA1c TARGET (58 mmol/mol (7.5%))",
			"entities": {
				"single": {
					"type": "algorithm_set_goal_1",
					"id": 3
				}
			}
		},
		{
			"id": "1.32",
			"node_type": "decision",
			"text": "SU CONTRAINDICATED?",
			"entities": {
				"single": {
					"type": "algorithm_medication_contraindication_decision_1",
					"id": 3
				}
			}
		},
		{
			"id": "1.33",
			"node_type": "action",
			"text": "LET M3 ∈ {GLIBENCLAMIDE, GLICLZIDE, GLIMEPIRIDE, GLIPIZIDE, TOLUBTAMIDE}",
			"entities": {
				"single": {
					"type": "algorithm_medication_choice_1",
					"code": "M3"
				}
			}
		},
		{
			"id": "1.34",
			"node_type": "decision",
			"text": "M3 CONTRAINDICATED?",
			"entities": {
				"single": {
					"type": "algorithm_medication_contraindication_decision_1",
					"code": "M3"
				}
			}
		},
		{
			"id": "1.35",
			"text": "CONSIDER M3",
			"node_type": "action",
			"entities": {
				"single": {
					"type": "algorithm_consider_medication_1",
					"code": "M3"
				}
			}
		},
		{
			"id": "1.36",
			"text": "HbA1c > 58 mmol/mol?",
			"node_type": "decision",
			"entities": {
				"single": {
					"type": "algorithm_observation_decision_1",
					"id": 3
				}
			}
		},
		{
			"id": "1.37",
			"node_type": "action",
			"text": "UPDATE HbA1c TARGET (58 mmol/mol (7.5%))",
			"entities": {
				"single": {
					"type": "algorithm_set_goal_1",
					"id": 3
				}
			}
		},
		{
			"id": "2.1",
			"node_type": "decision",
			"text": "SGLT-2i CONTRAINDICATED?",
			"entities": {
				"single": {
					"type": "algorithm_medication_contraindication_decision_1",
					"id": 4
				}
			}
		},
		{
			"id": "2.2",
			"node_type": "action",
			"text": "LET M1 ∈ {DAPAGLIFLOZIN, CANAGLIFLOZIN, EMPAGLIFLOZIN, ERTUGLIFLOZIN}",
			"entities": {
				"single": {
					"type": "algorithm_medication_choice_1",
					"id": 1,
					"code": "M13"
				}
			}
		},
		{
			"id": "2.3",
			"node_type": "decision",
			"text": "M13 CONTRAINDICATED?",
			"entities": {
				"single": {
					"type": "algorithm_medication_contraindication_decision_1",
					"code": "M13"
				}
			}
		},
		{
			"id": "2.4",
			"text": "CONSIDER M13 + METFORMIN",
			"node_type": "action",
			"entities": {
				"and": [
					{
						"type": "algorithm_consider_medication_1",
						"code": "M13"
					},
					{
						"type": "algorithm_consider_medication_1",
						"id": 1
					}
				]
			}
		},
		{
			"id": "2.5",
			"text": "HbA1c > 58 mmol/mol?",
			"node_type": "decision",
			"entities": {
				"single": {
					"type": "algorithm_observation_decision_1",
					"id": 3
				}
			}
		},
		{
			"id": "2.6",
			"node_type": "action",
			"text": "UPDATE HbA1c TARGET (58 mmol/mol (7.5%))",
			"entities": {
				"single": {
					"type": "algorithm_set_goal_1",
					"id": 3
				}
			}
		},
		{
			"id": "2.7",
			"node_type": "decision",
			"text": "SU CONTRAINDICATED?",
			"entities": {
				"single": {
					"type": "algorithm_medication_contraindication_decision_1",
					"id": 3
				}
			}
		},
		{
			"id": "2.8",
			"node_type": "action",
			"text": "LET M4 ∈ {GLIBENCLAMIDE, GLICLZIDE, GLIMEPIRIDE, GLIPIZIDE, TOLUBTAMIDE}",
			"entities": {
				"single": {
					"type": "algorithm_medication_choice_1",
					"id": 3,
					"code": "M4"
				}
			}
		},
		{
			"id": "2.9",
			"node_type": "decision",
			"text": "M4 CONTRAINDICATED?",
			"entities": {
				"single": {
					"type": "algorithm_medication_contraindication_decision_1",
					"code": "M4"
				}
			}
		},
		{
			"id": "2.10",
			"text": "CONSIDER M4 + METFORMIN",
			"node_type": "action",
			"entities": {
				"and": [
					{
						"type": "algorithm_consider_medication_1",
						"code": "M4"
					},
					{
						"type": "algorithm_consider_medication_1",
						"id": 1
					}
				]
			}
		},
		{
			"id": "2.11",
			"text": "HbA1c > 58 mmol/mol?",
			"node_type": "decision",
			"entities": {
				"single": {
					"type": "algorithm_observation_decision_1",
					"id": 3
				}
			}
		},
		{
			"id": "2.12",
			"node_type": "action",
			"text": "UPDATE HbA1c TARGET (58 mmol/mol (7.5%))",
			"entities": {
				"single": {
					"type": "algorithm_set_goal_1",
					"id": 3
				}
			}
		},
		{
			"id": "2.13",
			"node_type": "decision",
			"text": "PIOGLITAZONE CONTRAINDICATED?",
			"entities": {
				"single": {
					"type": "medication_contraindication_decision_1",
					"id": 2
				}
			}
		},
		{
			"id": "2.14",
			"text": "CONSIDER PIOGLITAZONE + METFORMIN",
			"node_type": "action",
			"entities": {
				"and": [
					{
						"type": "algorithm_consider_medication_1",
						"id": 2
					},
					{
						"type": "algorithm_consider_medication_1",
						"id": 1
					}
				]
			}
		},
		{
			"id": "2.15",
			"text": "SET ALERT ON PIOGLITAZONE CONTRAINDICATIONS STOP PIOGLITAZONE",
			"node_type": "action",
			"entities": {
				"single": {
					"type": "algorithm_set_alert_2",
					"id": 1
				}
			}
		},
		{
			"id": "2.16",
			"text": "HbA1c > 58 mmol/mol?",
			"node_type": "decision",
			"entities": {
				"single": {
					"type": "algorithm_observation_decision_1",
					"id": 3
				}
			}
		},
		{
			"id": "2.17",
			"node_type": "action",
			"text": "UPDATE HbA1c TARGET (58 mmol/mol (7.5%))",
			"entities": {
				"single": {
					"type": "algorithm_set_goal_1",
					"id": 3
				}
			}
		},
		{
			"id": "2.18",
			"node_type": "decision",
			"text": "DPP-4i CONTRAINDICATED?",
			"entities": {
				"single": {
					"type": "algorithm_medication_contraindication_decision_1",
					"id": 5
				}
			}
		},
		{
			"id": "2.19",
			"node_type": "action",
			"text": "LET M5 ∈ {ALOGLIPTIN, LINGLIPTIN, SAXAGLIPTIN, SITAGLIPTIN, VILDAGLIPTIN}",
			"entities": {
				"single": {
					"type": "algorithm_medication_choice_1",
					"id": 2,
					"code": "M5"
				}
			}
		},
		{
			"id": "2.20",
			"node_type": "decision",
			"text": "M5 CONTRAINDICATED?",
			"entities": {
				"single": {
					"type": "algorithm_medication_contraindication_decision_1",
					"code": "M5"
				}
			}
		},
		{
			"id": "2.21",
			"text": "CONSIDER M2 + METFORMIN",
			"node_type": "action",
			"entities": {
				"and": [
					{
						"type": "algorithm_consider_medication_1",
						"code": "M2"
					},
					{
						"type": "algorithm_consider_medication_1",
						"code": 1
					}
				]
			}
		},
		{
			"id": "2.22",
			"text": "HbA1c > 58 mmol/mol?",
			"node_type": "decision",
			"entities": {
				"single": {
					"type": "algorithm_observation_decision_1",
					"id": 3
				}
			}
		},
		{
			"id": "2.23",
			"node_type": "action",
			"text": "UPDATE HbA1c TARGET (58 mmol/mol (7.5%))",
			"entities": {
				"single": {
					"type": "algorithm_set_goal_1",
					"id": 3
				}
			}
		},
		{
			"id": "2.24",
			"node_type": "decision",
			"text": "DPP-4i CONTRAINDICATED?",
			"entities": {
				"single": {
					"type": "algorithm_medication_contraindication_decision_1",
					"id": 5
				}
			}
		},
		{
			"id": "2.25",
			"node_type": "action",
			"text": "LET M6 ∈ {ALOGLIPTIN, LINGLIPTIN, SAXAGLIPTIN, SITAGLIPTIN, VILDAGLIPTIN}",
			"entities": {
				"single": {
					"type": "algorithm_medication_choice_1",
					"id": 2,
					"code": "M6"
				}
			}
		},
		{
			"id": "2.26",
			"node_type": "decision",
			"text": "M6 CONTRAINDICATED?",
			"entities": {
				"single": {
					"type": "algorithm_medication_contraindication_decision_1",
					"code": "M6"
				}
			}
		},
		{
			"id": "2.27",
			"text": "CONSIDER M6 + PIOGLITAZONE",
			"node_type": "action",
			"entities": {
				"and": [
					{
						"type": "algorithm_consider_medication_1",
						"code": "M6"
					},
					{
						"type": "algorithm_consider_medication_1",
						"code": 2
					}
				]
			}
		},
		{
			"id": "2.28",
			"text": "HbA1c > 58 mmol/mol?",
			"node_type": "decision",
			"entities": {
				"single": {
					"type": "algorithm_observation_decision_1",
					"id": 3
				}
			}
		},
		{
			"id": "2.29",
			"node_type": "decision",
			"text": "PIOGLITAZONE CONTRAINDICATED?",
			"entities": {
				"single": {
					"type": "medication_contraindication_decision_1",
					"id": 2
				}
			}
		},
		{
			"id": "2.30",
			"text": "CONSIDER PIOGLITAZONE + METFORMIN",
			"node_type": "action",
			"entities": {
				"and": [
					{
						"type": "algorithm_consider_medication_1",
						"code": "M2"
					},
					{
						"type": "algorithm_consider_medication_1",
						"id": 2
					}
				]
			}
		},
		{
			"id": "2.31",
			"text": "SET ALERT ON PIOGLITAZONE CONTRAINDICATIONS STOP PIOGLITAZONE",
			"node_type": "action",
			"entities": {
				"single": {
					"type": "algorithm_set_alert_2",
					"id": 1
				}
			}
		},
		{
			"id": "2.32",
			"text": "HbA1c > 58 mmol/mol?",
			"node_type": "decision",
			"entities": {
				"single": {
					"type": "algorithm_observation_decision_1",
					"id": 3
				}
			}
		},
		{
			"id": "2.33",
			"node_type": "decision",
			"text": "SU CONTRAINDICATED?",
			"entities": {
				"single": {
					"type": "algorithm_medication_contraindication_decision_1",
					"id": 3
				}
			}
		},
		{
			"id": "2.34",
			"node_type": "action",
			"text": "LET M7 ∈ {GLIBENCLAMIDE, GLICIZIDE, GLIMEPIRIDE, GLIPIZIDE, TOLUBTAMIDE}",
			"entities": {
				"single": {
					"type": "algorithm_medication_choice_1",
					"id": 3,
					"code": "M7"
				}
			}
		},
		{
			"id": "2.35",
			"node_type": "decision",
			"text": "M7 CONTRAINDICATED?",
			"entities": {
				"single": {
					"type": "algorithm_medication_contraindication_decision_1",
					"code": "M7"
				}
			}
		},
		{
			"id": "2.36",
			"text": "CONSIDER M7 + M2",
			"node_type": "action",
			"entities": {
				"and": [
					{
						"type": "algorithm_consider_medication_1",
						"code": "M7"
					},
					{
						"type": "algorithm_consider_medication_1",
						"code": "M2"
					}
				]
			}
		},
		{
			"id": "2.37",
			"text": "HbA1c > 58 mmol/mol?",
			"node_type": "decision",
			"entities": {
				"single": {
					"type": "algorithm_observation_decision_1",
					"id": 3
				}
			}
		},
		{
			"id": "2.38",
			"node_type": "decision",
			"text": "SU CONTRAINDICATED?",
			"entities": {
				"single": {
					"type": "algorithm_medication_contraindication_decision_1",
					"id": 3
				}
			}
		},
		{
			"id": "2.39",
			"node_type": "action",
			"text": "LET M7 ∈ {GLIBENCLAMIDE, GLICLZIDE, GLIMEPIRIDE, GLIPIZIDE, TOLUBTAMIDE}",
			"entities": {
				"single": {
					"type": "algorithm_medication_choice_1",
					"id": 3,
					"code": "M7"
				}
			}
		},
		{
			"id": "2.40",
			"node_type": "decision",
			"text": "M7 CONTRAINDICATED?",
			"entities": {
				"single": {
					"type": "algorithm_medication_contraindication_decision_1",
					"code": "M7"
				}
			}
		},
		{
			"id": "2.41",
			"text": "CONSIDER M7 + PIOGLITAZONE",
			"node_type": "action",
			"entities": {
				"and": [
					{
						"type": "algorithm_consider_medication_1",
						"code": "M7"
					},
					{
						"type": "algorithm_consider_medication_1",
						"code": 2
					}
				]
			}
		},
		{
			"id": "2.42",
			"text": "HbA1c > 58 mmol/mol?",
			"node_type": "decision",
			"entities": {
				"single": {
					"type": "algorithm_observation_decision_1",
					"id": 3
				}
			}
		},
		{
			"id": "2.43",
			"node_type": "decision",
			"text": "DPP-4i CONTRAINDICATED?",
			"entities": {
				"single": {
					"type": "algorithm_medication_contraindication_decision_1",
					"id": 5
				}
			}
		},
		{
			"id": "2.44",
			"node_type": "action",
			"text": "LET M9 ∈ {ALOGLIPTIN, LINGLIPTIN, SAXAGLIPTIN, SITAGLIPTIN, VILDAGLIPTIN}",
			"entities": {
				"single": {
					"type": "algorithm_medication_choice_1",
					"id": 2,
					"code": "M9"
				}
			}
		},
		{
			"id": "2.45",
			"node_type": "decision",
			"text": "M9 CONTRAINDICATED?",
			"entities": {
				"single": {
					"type": "algorithm_medication_contraindication_decision_1",
					"code": "M9"
				}
			}
		},
		{
			"id": "2.46",
			"text": "CONSIDER M9 + M3",
			"node_type": "action",
			"entities": {
				"and": [
					{
						"type": "algorithm_consider_medication_1",
						"code": "M9"
					},
					{
						"type": "algorithm_consider_medication_1",
						"code": "M3"
					}
				]
			}
		},
		{
			"id": "2.47",
			"text": "HbA1c > 58 mmol/mol?",
			"node_type": "decision",
			"entities": {
				"single": {
					"type": "algorithm_observation_decision_1",
					"id": 3
				}
			}
		},
		{
			"id": "3.1",
			"node_type": "decision",
			"text": "PIOGLITAZONE CONTRAINDICATED?",
			"entities": {
				"single": {
					"type": "medication_contraindication_decision_1",
					"id": 2
				}
			}
		},
		{
			"id": "3.2",
			"text": "CONSIDER PIOGLITAZONE",
			"node_type": "action",
			"entities": {
				"and": [
					{
						"type": "algorithm_consider_medication_1",
						"id": 2
					},
					{
						"type": "algorithm_consider_medication_1",
						"id": 1
					},
					{
						"type": "algorithm_consider_medication_1",
						"code": "M13"
					}
				]
			}
		},
		{
			"id": "3.3",
			"text": "SET ALERT ON PIOGLITAZONE CONTRAINDICATIONS STOP PIOGLITAZONE",
			"node_type": "action",
			"entities": {
				"single": {
					"type": "algorithm_set_alert_2",
					"id": 1
				}
			}
		},
		{
			"id": "3.4",
			"text": " PIOGLITIZONE / M13 / METFORMIN CONTRAINDICATED?",
			"node_type": "decision",
			"entities": {
				"or": [
					{
						"type": "algorithm_medication_contraindication_descision_1",
						"id": 2
					},
					{
						"type": "algorithm_medication_contraindication_descision_1",
						"id": 1
					},
					{
						"type": "algorithm_medication_contraindication_descision_1",
						"code": "M13"
					}
				]
			}
		},
		{
			"id": "3.5",
			"text": " PIOGLITIZONE / M13 / METFORMIN NOT TOLERATED?",
			"node_type": "decision",
			"entities": {
				"or": [
					{
						"type": "algorithm_medication_not_tolerated_decision_1",
						"id": 2
					},
					{
						"type": "algorithm_medication_not_tolerated_decision_1",
						"id": 1
					},
					{
						"type": "algorithm_medication_not_tolerated_decision_1",
						"code": "M13"
					}
				]
			}
		},
		{
			"id": "3.6",
			"text": "HbA1c > 58 mmol/mol?",
			"node_type": "decision",
			"entities": {
				"single": {
					"type": "algorithm_observation_decision_1",
					"id": 3
				}
			}
		},
		{
			"id": "3.7",
			"node_type": "decision",
			"text": "SU CONTRAINDICATED?",
			"entities": {
				"single": {
					"type": "algorithm_medication_contraindication_decision_1",
					"id": 3
				}
			}
		},
		{
			"id": "3.8",
			"node_type": "action",
			"text": "LET M14 ∈ {GLIBENCLAMIDE, GLICLZIDE, GLIMEPIRIDE, GLIPIZIDE, TOLUBTAMIDE}",
			"entities": {
				"single": {
					"type": "algorithm_medication_choice_1",
					"id": 3,
					"code": "M14"
				}
			}
		},
		{
			"id": "3.9",
			"node_type": "decision",
			"text": "M14 CONTRAINDICATED?",
			"entities": {
				"single": {
					"type": "algorithm_medication_contraindication_decision_1",
					"code": "M14"
				}
			}
		},
		{
			"id": "3.10",
			"text": "CONSIDER M14 + METFORMIN + M13",
			"node_type": "action",
			"entities": {
				"and": [
					{
						"type": "algorithm_consider_medication_1",
						"code": "M14"
					},
					{
						"type": "algorithm_consider_medication_1",
						"code": "M13"
					},
					{
						"type": "algorithm_consider_medication_1",
						"id": 1
					}
				]
			}
		},
		{
			"id": "3.11",
			"text": "HbA1c > 58 mmol/mol?",
			"node_type": "decision",
			"entities": {
				"single": {
					"type": "algorithm_observation_decision_1",
					"id": 3
				}
			}
		},
		{
			"id": "3.12",
			"text": " M14 / M13 / METFORMIN NOT TOLERATED?",
			"node_type": "decision",
			"entities": {
				"or": [
					{
						"type": "algorithm_medication_not_tolerated_decision_1",
						"id": 1
					},
					{
						"type": "algorithm_medication_not_tolerated_decision_1",
						"code": "M14"
					},
					{
						"type": "algorithm_medication_not_tolerated_decision_1",
						"code": "M13"
					}
				]
			}
		},
		{
			"id": "3.13",
			"text": " M14 / M13 / METFORMIN CONTRAINDICATED?",
			"node_type": "decision",
			"entities": {
				"or": [
					{
						"type": "algorithm_medication_not_tolerated_decision_1",
						"code": "M14"
					},
					{
						"type": "algorithm_medication_contraindication_descision_1",
						"id": 1
					},
					{
						"type": "algorithm_medication_contraindication_descision_1",
						"code": "M13"
					}
				]
			}
		},
		{
			"id": "3.14",
			"node_type": "decision",
			"text": "DPP-4i CONTRAINDICATED?",
			"entities": {
				"single": {
					"type": "algorithm_medication_contraindication_decision_1",
					"id": 5
				}
			}
		},
		{
			"id": "3.15",
			"node_type": "action",
			"text": "LET M10 ∈ {ALOGLIPTIN, LINGLIPTIN, SAXAGLIPTIN, SITAGLIPTIN, VILDAGLIPTIN}",
			"entities": {
				"single": {
					"type": "algorithm_medication_choice_1",
					"id": 2,
					"code": "M10"
				}
			}
		},
		{
			"id": "3.16",
			"node_type": "decision",
			"text": "M10 CONTRAINDICATED?",
			"entities": {
				"single": {
					"type": "algorithm_medication_contraindication_decision_1",
					"code": "M10"
				}
			}
		},
		{
			"id": "3.17",
			"text": "CONSIDER M10 + M4 + METFORMIN",
			"node_type": "action",
			"entities": {
				"and": [
					{
						"type": "algorithm_consider_medication_1",
						"code": "M4"
					},
					{
						"type": "algorithm_consider_medication_1",
						"code": "M10"
					},
					{
						"type": "algorithm_consider_medication_1",
						"id": 1
					}
				]
			}
		},
		{
			"id": "3.18",
			"text": "HbA1c > 58 mmol/mol?",
			"node_type": "decision",
			"entities": {
				"single": {
					"type": "algorithm_observation_decision_1",
					"id": 3
				}
			}
		},
		{
			"id": "3.19",
			"text": " M10 / M4 / METFORMIN NOT TOLERATED?",
			"node_type": "decision",
			"entities": {
				"or": [
					{
						"type": "algorithm_medication_not_tolerated_decision_1",
						"id": 1
					},
					{
						"type": "algorithm_medication_not_tolerated_decision_1",
						"code": "M10"
					},
					{
						"type": "algorithm_medication_not_tolerated_decision_1",
						"code": "M4"
					}
				]
			}
		},
		{
			"id": "3.20",
			"text": " M10 / M4 / METFORMIN CONTRAINDICATED?",
			"node_type": "decision",
			"entities": {
				"or": [
					{
						"type": "algorithm_medication_not_tolerated_decision_1",
						"code": "M10"
					},
					{
						"type": "algorithm_medication_contraindication_descision_1",
						"id": 1
					},
					{
						"type": "algorithm_medication_contraindication_descision_1",
						"code": "M4"
					}
				]
			}
		},
		{
			"id": "3.21",
			"node_type": "decision",
			"text": "SU CONTRAINDICATED?",
			"entities": {
				"single": {
					"type": "algorithm_medication_contraindication_decision_1",
					"id": 3
				}
			}
		},
		{
			"id": "3.22",
			"node_type": "action",
			"text": "LET M11 ∈ {GLIBENCLAMIDE, GLICLZIDE, GLIMEPIRIDE, GLIPIZIDE, TOLUBTAMIDE}",
			"entities": {
				"single": {
					"type": "algorithm_medication_choice_1",
					"id": 3,
					"code": "M11"
				}
			}
		},
		{
			"id": "3.23",
			"node_type": "decision",
			"text": "M11 CONTRAINDICATED?",
			"entities": {
				"single": {
					"type": "algorithm_medication_contraindication_decision_1",
					"code": "M11"
				}
			}
		},
		{
			"id": "3.24",
			"text": "CONSIDER M11 + METFORMIN + PIOGLITAZONE",
			"node_type": "action",
			"entities": {
				"and": [
					{
						"type": "algorithm_consider_medication_1",
						"code": "M14"
					},
					{
						"type": "algorithm_consider_medication_1",
						"id": 2
					},
					{
						"type": "algorithm_consider_medication_1",
						"id": 1
					}
				]
			}
		},
		{
			"id": "3.25",
			"text": "HbA1c > 58 mmol/mol?",
			"node_type": "decision",
			"entities": {
				"single": {
					"type": "algorithm_observation_decision_1",
					"id": 3
				}
			}
		},
		{
			"id": "3.26",
			"text": " PIOGLITIZONE / M11 / METFORMIN NOT TOLERATED?",
			"node_type": "decision",
			"entities": {
				"or": [
					{
						"type": "algorithm_medication_not_tolerated_decision_1",
						"id": 1
					},
					{
						"type": "algorithm_medication_not_tolerated_decision_1",
						"id": 2
					},
					{
						"type": "algorithm_medication_not_tolerated_decision_1",
						"code": "M11"
					}
				]
			}
		},
		{
			"id": "3.27",
			"text": " PIOGLITIZONE / M11 / METFORMIN CONTRAINDICATED?",
			"node_type": "decision",
			"entities": {
				"or": [
					{
						"type": "algorithm_medication_not_tolerated_decision_1",
						"code": "M11"
					},
					{
						"type": "algorithm_medication_contraindication_descision_1",
						"id": 1
					},
					{
						"type": "algorithm_medication_contraindication_descision_1",
						"id": 2
					}
				]
			}
		},
		{
			"id": "3.28",
			"node_type": "decision",
			"text": "SU CONTRAINDICATED?",
			"entities": {
				"single": {
					"type": "algorithm_medication_contraindication_decision_1",
					"id": 3
				}
			}
		},
		{
			"id": "3.29",
			"node_type": "action",
			"text": "LET M11 ∈ {GLIBENCLAMIDE, GLICLZIDE, GLIMEPIRIDE, GLIPIZIDE, TOLUBTAMIDE}",
			"entities": {
				"single": {
					"type": "algorithm_medication_choice_1",
					"id": 3,
					"code": "M11"
				}
			}
		},
		{
			"id": "3.30",
			"node_type": "decision",
			"text": "M12 CONTRAINDICATED?",
			"entities": {
				"single": {
					"type": "algorithm_medication_contraindication_decision_1",
					"code": "M12"
				}
			}
		},
		{
			"id": "3.31",
			"text": "CONSIDER M12 + METFORMIN + M5",
			"node_type": "action",
			"entities": {
				"and": [
					{
						"type": "algorithm_consider_medication_1",
						"code": "M12"
					},
					{
						"type": "algorithm_consider_medication_1",
						"code": "M5"
					},
					{
						"type": "algorithm_consider_medication_1",
						"id": 1
					}
				]
			}
		},
		{
			"id": "3.32",
			"text": "HbA1c > 58 mmol/mol?",
			"node_type": "decision",
			"entities": {
				"single": {
					"type": "algorithm_observation_decision_1",
					"id": 3
				}
			}
		},
		{
			"id": "3.33",
			"text": " M12 / M5 / METFORMIN NOT TOLERATED?",
			"node_type": "decision",
			"entities": {
				"or": [
					{
						"type": "algorithm_medication_not_tolerated_decision_1",
						"id": 1
					},
					{
						"type": "algorithm_medication_not_tolerated_decision_1",
						"code": "M12"
					},
					{
						"type": "algorithm_medication_not_tolerated_decision_1",
						"code": "M5"
					}
				]
			}
		},
		{
			"id": "3.34",
			"text": " M12 / M5 / METFORMIN CONTRAINDICATED?",
			"node_type": "decision",
			"entities": {
				"or": [
					{
						"type": "algorithm_medication_not_tolerated_decision_1",
						"code": "M12"
					},
					{
						"type": "algorithm_medication_contraindication_descision_1",
						"code": "M5"
					},
					{
						"type": "algorithm_medication_contraindication_descision_1",
						"id": 1
					}
				]
			}
		},
		{
			"id": "4.1",
			"text": "BMI > 35?",
			"node_type": "decision",
			"entities": {
				"single": {
					"type": "algorithm_observation_decision_1",
					"id": 4
				}
			}
		},
		{
			"id": "4.2",
			"text": "BMI < 35?",
			"node_type": "decision",
			"entities": {
				"single": {
					"type": "algorithm_observation_decision_1",
					"id": 5
				}
			}
		},
		{
			"id": "4.3",
			"text": "PSYCHOLOGICAL DISORDER?",
			"node_type": "decision",
			"entities": {
				"single": {
					"type": "algorithm_condition_decision_1",
					"id": 3
				}
			}
		},
		{
			"id": "4.4",
			"text": "DISORDER ASSOCIATED WITH OBESITY?",
			"node_type": "decision",
			"entities": {
				"single": {
					"type": "algorithm_condition_decision_1",
					"id": 4
				}
			}
		},
		{
			"id": "4.5",
			"text": "INSULIN HAS SIGNIFICANT OCCUPATIONAL IMPLICATIONS?",
			"node_type": "decision",
			"entities": {
				"single": {
					"type": "algorithm_clinician_decision_1",
					"id": 1
				}
			}
		},
		{
			"id": "4.6",
			"text": "WEIGHT LOSS WOULD BENEFIT OTHER SIGNIFICANT OBESITY RELATED COMORBIDITIES?",
			"node_type": "decision",
			"entities": {
				"single": {
					"type": "algorithm_clinician_decision_1",
					"id": 2
				}
			}
		},
		{
			"id": "4.7",
			"node_type": "decision",
			"text": "SU CONTRAINDICATED?",
			"entities": {
				"single": {
					"type": "algorithm_medication_contraindication_decision_1",
					"id": 3
				}
			}
		},
		{
			"id": "4.8",
			"node_type": "decision",
			"text": "GLP-1 CONTRAINDICATED?",
			"entities": {
				"single": {
					"type": "algorithm_medication_contraindication_decision_1",
					"id": 3
				}
			}
		},
		{
			"id": "4.9",
			"node_type": "action",
			"text": "LET M15 ∈ {GLIBENCLAMIDE, GLICLZIDE, GLIMEPIRIDE, GLIPIZIDE, TOLUBTAMIDE}",
			"entities": {
				"single": {
					"type": "algorithm_medication_choice_1",
					"code": "M15"
				}
			}
		},
		{
			"id": "4.10",
			"text": "CONSIDER M15 + GLP-1 + METFORMIN",
			"node_type": "action",
			"entities": {
				"and": [
					{
						"type": "algorithm_consider_medication_1",
						"code": "M15"
					},
					{
						"type": "algorithm_consider_medication_1",
						"id": 3
					},
					{
						"type": "algorithm_consider_medication_1",
						"id": 1
					}
				]
			}
		}
	],
	
	"name":"Algorithm for blood glucose lowering therapy in adults with type 2 diabetes"
}